Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 217, pseudogene (RNU6-217P)
- Target
- RNU6-217P
- Molecular classification
- Other
01
Overview
RNA, U6 small nuclear 217, pseudogene (RNU6-217P) is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is a highly conserved, non-coding small nuclear RNA that is a functional component of the spliceosome, essential for catalyzing the excision of introns from pre-mRNA during RNA splicing[1][3][5]. However, RNU6-217P itself is a pseudogene: a non-functional, often intronless genomic sequence generated via retrotransposition and lacking the necessary regulatory elements or sequence integrity to produce functional RNA or protein products[5]. Such pseudogenes are evolutionary relics, abundant in vertebrate genomes, and do not encode active biomolecules or play direct roles as therapeutic targets, disease genes, or biomarkers. There is no evidence that RNU6-217P participates in biological processes or disease, nor are there any drugs or known safety concerns related to this sequence[5].
- Other names
- RNU6-217PRNA, U6 small nuclear 217, pseudogene
Beyond the preview
Go deeper on RNA, U6 small nuclear 217, pseudogene (RNU6-217P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 217, pseudogene (RNU6-217P).